A detailed history of Arrow Mark Colorado Holdings LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,394,947 shares of MXCT stock, worth $6.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,394,947
Previous 1,225,697 13.81%
Holding current value
$6.5 Million
Previous $4.8 Million 12.95%
% of portfolio
0.08%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.68 - $5.06 $622,840 - $856,404
169,250 Added 13.81%
1,394,947 $5.43 Million
Q2 2024

Aug 14, 2024

SELL
$3.63 - $5.0 $117,985 - $162,515
-32,503 Reduced 2.58%
1,225,697 $4.8 Million
Q1 2024

May 15, 2024

SELL
$3.94 - $5.38 $455,373 - $621,804
-115,577 Reduced 8.41%
1,258,200 $5.27 Million
Q4 2023

Feb 14, 2024

SELL
$2.6 - $5.24 $3.13 Million - $6.3 Million
-1,202,483 Reduced 46.68%
1,373,777 $6.46 Million
Q2 2023

Aug 14, 2023

BUY
$3.69 - $5.35 $1.02 Million - $1.48 Million
277,186 Added 12.06%
2,576,260 $11.8 Million
Q1 2023

May 15, 2023

BUY
$4.03 - $5.89 $164,593 - $240,559
40,842 Added 1.81%
2,299,074 $11.4 Million
Q4 2022

Feb 14, 2023

BUY
$4.92 - $7.4 $148,254 - $222,984
30,133 Added 1.35%
2,258,232 $12.3 Million
Q3 2022

Nov 14, 2022

BUY
$4.52 - $6.51 $333,856 - $480,841
73,862 Added 3.43%
2,228,099 $14.5 Million
Q2 2022

Aug 15, 2022

BUY
$3.59 - $6.81 $3.09 Million - $5.87 Million
861,524 Added 66.64%
2,154,237 $10.2 Million
Q1 2022

May 16, 2022

BUY
$5.26 - $10.84 $373,265 - $769,238
70,963 Added 5.81%
1,292,713 $9.04 Million
Q4 2021

Feb 14, 2022

BUY
$8.87 - $12.94 $388,736 - $567,108
43,826 Added 3.72%
1,221,750 $12.4 Million
Q3 2021

Nov 15, 2021

BUY
$12.21 - $17.2 $14.4 Million - $20.3 Million
1,177,924 New
1,177,924 $14.4 Million

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $474M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.